Impacts of Antimicrobial Resistance on Cancer Care

Sujan C. Reddy, MD, MSc
Infectious Disease Physician and Director for the Office of Prevention Research and Evaluation, U.S. Centers for Disease Control and Prevention

Sujan Reddy, MD, MSc, is an Infectious Disease Physician and Director for the Office of Prevention Research and Evaluation in the Division of Healthcare Quality Promotion at CDC’s National Center for Emerging and Zoonotic Infectious Diseases. Dr. Reddy works to address knowledge gaps in the prevention of healthcare-associated infections (HAIs) and other adverse events related to health care. He is the Medical Director of CDC’s Prevention Epicenters Program, a collaborative network of academic medical centers addressing scientific questions regarding prevention of HAIs, antimicrobial resistance, microbiome health, and other healthcare-associated adverse events.

Joshua (Josh) Glasser, MS
Assistant Director for Combatting Antimicrobial Resistance and Integrated Health Innovation, White House Office of Science and Technology Policy

Joshua (Josh) Glasser, MS, is the Assistant Director for Combatting Antimicrobial Resistance and Integrated Health Innovation with the White House Office of Science Technology Policy (OSTP). He came to OSTP having previously served as acting Head of Strategy for the U.S. Department of State's Bureau of Global Health Security and Diplomacy. He has also served as a Foreign Affairs Officer and Senior Advisor for the Department’s Office of International Health and Biodefense. During his decade at the State Department, he held a portfolio focused on health security and the global environment. Josh has worked on a variety of human-animal-environmental health ("One Health") and climate-related topics, including in the Arctic region, the Asia-Pacific region, Latin America, sub-Saharan Africa and in multilateral contexts such as World Health Organization and the United Nations Framework Convention on Climate Change. Josh joined the State Department as a Presidential Management Fellow in 2013; his work has been recognized with two Superior Honor Awards, several Meritorious Honor Awards, a Franklin Award, and a Director's Award from the National Institute of Mental Health.

Lillian Sung, MD, PhD
Professor, Senior Scientist and the Chief Clinical Data Scientist, The Hospital for Sick Children

Lillian Sung, MD, PhD, is a Professor, Senior Scientist and the Chief Clinical Data Scientist at The Hospital for Sick Children, Toronto, Ontario, Canada. Dr. Sung is certified in pediatrics, infectious diseases, hematology, and clinical investigation. She completed a PhD in Clinical Epidemiology from the University of Toronto. Dr. Sung leads an independent clinical research program focused on improving supportive care for children with cancer and implementing machine learning. Her methodological focus is on randomized and observational trials, meta-analysis, and patient-reported outcomes. She holds a Tier 1 Canada Research Chair in Pediatric Oncology Supportive Care and is the principal investigator on multiple operating grants from the National Institutes of Health, Canadian Cancer Society Research Institute, and the Canadian Institutes of Health Research. Her overall goal is to optimize supportive care for children with cancer, with the aim to maximize quality of life, survival, and cost-effectiveness.

Shalini Jayasekar-Zürn, MSc
Senior Advocacy Manager, Union for International Cancer Control (UICC)

Shalini Jayasekar-Zürn, MSc, is a Senior Advocacy Manager with the Union for International Cancer Control, focusing on all treatment-related issues, including antimicrobial resistance. Zürn is a biologist by training and has worked extensively on the issues of access to medicines, including with the World Health Organization on their Model List of Essential Medicines and Médecins Sans Frontières’s access campaign. She also has experience working with other non-governmental organizations and the pharmaceutical industry.

Diane Flayhart, MBA
Director, Global Public Health, AMR, BD

Diane Flayhart, MBA, is the Director and Global Program Leader for Antimicrobial Resistance at BD. She drives efforts to align global public health initiatives with business priorities to advance cross-sector engagements. Flayhart works with global stakeholders in a collaborative and programmatic approach that expands health access and strengthens health systems. She also leads efforts for the Antimicrobial Resistance Fighter Coalition, a global organization that seeks to substantially increase awareness of antimicrobial-resistant infections and encourage action.

Jennifer (Jen) Wargo, MD, MMSc
Professor, Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center

Jennifer (Jen) Wargo, MD, MMSc, is a Professor of Surgical Oncology and Genomic Medicine and the leader of the Platform for Innovative Microbiome and Translational Research (PRIME-TR) at The University of Texas MD Anderson Cancer Center. Her research examines the role of the gut microbiome in cancer immunotherapy response. During surgical residency training at Massachusetts General Hospital, she became interested in the biology and treatment of cancer and completed two fellowships in surgical oncology with a focus on cancer immunotherapy. In 2008, Dr. Wargo joined the faculty at Massachusetts General Hospital’s Division of Surgical Oncology and established a translational research laboratory focusing on better understanding response and resistance to treatment for melanoma, pancreatic cancer, and other cancers. In 2013, Dr. Wargo joined the University of Texas MD Anderson Cancer Center to help lead the Melanoma Moonshot efforts and continued translational research work on targeted therapy, immunotherapy, and the impact of the gut and tumor microbiome in cancer. She is deeply invested in working with investigators across the institution and across the world to find better ways to treat, intercept, and ultimately prevent cancer.

Mini Kamboj, MD
Infectious Disease Physician and Chief Medical Epidemiologist, Memorial Sloan Kettering Cancer Center

Mini Kamboj, MD is a board-certified Infectious Disease Physician and Chief Medical Epidemiologist at Memorial Sloan Kettering Cancer Center. Her research interests include applying molecular diagnostic tools and whole genome sequencing techniques to elucidate transmission patterns of common gastrointestinal and respiratory nosocomial pathogens, with a critical focus on preventing hospital-based transmission of multi-drug resistant bacteria and common respiratory viruses in oncology and transplant settings.